Interestingly, in The Cancer Genome Atlas data PPFIA1 alteration was identified in 189 (36%) of 528 sequenced head and neck squamous cell carcinoma patients, whereas in breast cancer data set PPFIA1 amplification was identified in 439 (17%) of 2509 sequenced patients [21, 22]. Here, PPFIA1 is linked to breast carcinoma.